- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/70 - Carbohydrates; Sugars; Derivatives thereof
Patent holdings for IPC class A61K 31/70
Total number of patents in this class: 4359
10-year publication summary
238
|
255
|
228
|
208
|
171
|
154
|
139
|
108
|
108
|
24
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1066 |
67 |
The Regents of the University of California | 18943 |
59 |
Ionis Pharmaceuticals, Inc. | 776 |
47 |
Boehringer Ingelheim International GmbH | 4629 |
41 |
Gilead Sciences, Inc. | 1879 |
41 |
University of South Florida | 1817 |
37 |
Enanta Pharmaceuticals, Inc. | 420 |
35 |
AstraZeneca AB | 3042 |
33 |
Merck Sharp & Dohme LLC | 3689 |
32 |
The Johns Hopkins University | 5377 |
31 |
N.V. Nutricia | 1022 |
29 |
Board of Regents, The University of Texas System | 5370 |
27 |
President and Fellows of Harvard College | 5792 |
25 |
Isis Pharmaceuticals, Inc. | 255 |
25 |
Société des Produits Nestlé S.A. | 9672 |
23 |
The Trustees of Columbia University in the City of New York | 3440 |
22 |
The Scripps Research Institute | 1364 |
22 |
Novartis AG | 11238 |
20 |
The Regents of the University of Michigan | 4409 |
20 |
Centre National de La Recherche Scientifique | 9632 |
17 |
Other owners | 3706 |